GlassScriptPhysician profile
Venkatesh Anjan
NPI 1275799850
$20,484.07
in general payments reported to CMS, 2019-2025
16 companies · $5,099 in 2025
The $5,099 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,889 · 2020: $214 · 2021: $638 · 2022: $4,225 · 2023: $3,045 · 2024: $4,373 · 2025: $5,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,617 · Travel and Lodging: $5,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,616.73 |
| Travel and Lodging | $5,900.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,591.05 | 2021-2025 | Corevalve Evolut R, Ffrangio |
| Abbott Laboratories | $3,678.48 | 2019-2025 | Mitraclip, Triclip, Amplatzer Amulet |
| Edwards Lifesciences Corporation | $3,566.43 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Boston Scientific Corporation | $3,411.02 | 2019-2025 | Watchman Flx, Avvigo Guidance System, Watchman Access System |
| Abiomed | $956.60 | 2019-2025 | Impella |
| Shockwave Medical, INC | $631.66 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Medtronic Vascular, INC. | $213.31 | 2019-2020 | |
| Inari Medical, INC. | $114.42 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.84 | 2019-2020 | |
| Eko Health, INC. | $59.98 | 2023 | |
| Amgen INC. | $53.98 | 2019-2025 | Repatha |
| Philips North America LLC | $38.30 | 2019-2025 | Igt Devices Undivided |
| Biotronik INC. | $37.10 | 2021 | |
| Pfizer INC. | $32.45 | 2024 | |
| Cardiovascular Systems INC. | $23.96 | 2020-2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $14.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Venkatesh Anjan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.